Slingshot members are tracking this event:
DBV Technologies to report topline results from Phase 3 PEPITES of Viaskin Peanut in Peanut allergy in October 2017
Slingshot Insights Explained
Oct 20, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Pepites Trial, Viaskin